Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Suvorexant: The first orexin receptor antagonist to treat insomnia
Ashok Kumar Dubey, Shailendra Handu, Pramod Kumari Mediratta
Journal of Pharmacology and Pharmacotherapeutics (2015) Vol. 6, Iss. 2, pp. 118-121
Open Access | Times Cited: 64

Showing 1-25 of 64 citing articles:

Novel 1,2,4-Oxadiazole Derivatives in Drug Discovery
Karol Biernacki, Mateusz Daśko, Olga Ciupak, et al.
Pharmaceuticals (2020) Vol. 13, Iss. 6, pp. 111-111
Open Access | Times Cited: 139
Structures of active-state orexin receptor 2 rationalize peptide and small-molecule agonist recognition and receptor activation
Chuan Hong, Noel Byrne, Beata Zamlynny, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 104
Advances in the management of chronic insomnia
Margaret Kay-Stacey, Hrayr Attarian
BMJ (2016), pp. i2123-i2123
Closed Access | Times Cited: 144
Chronobesity: role of the circadian system in the obesity epidemic
Jorien Laermans, Inge Depoortere
Obesity Reviews (2015) Vol. 17, Iss. 2, pp. 108-125
Closed Access | Times Cited: 115
Lemborexant vs suvorexant for insomnia: A systematic review and network meta-analysis
Taro Kishi, Ikuo Nomura, Yuki Matsuda, et al.
Journal of Psychiatric Research (2020) Vol. 128, pp. 68-74
Closed Access | Times Cited: 79
Orexin Receptor Antagonists as Emerging Treatments for Psychiatric Disorders
Ying Han, Kai Yuan, Yongbo Zheng, et al.
Neuroscience Bulletin (2019) Vol. 36, Iss. 4, pp. 432-448
Open Access | Times Cited: 77
Suvorexant for Primary Insomnia: A Systematic Review and Meta-Analysis of Randomized Placebo-Controlled Trials
Taro Kishi, Shinji Matsunaga, Nakao Iwata
PLoS ONE (2015) Vol. 10, Iss. 8, pp. e0136910-e0136910
Open Access | Times Cited: 72
Crystal Structures of Human Orexin 2 Receptor Bound to the Subtype-Selective Antagonist EMPA
Ryoji Suno, Kanako Kimura, Takanori Nakane, et al.
Structure (2017) Vol. 26, Iss. 1, pp. 7-19.e5
Open Access | Times Cited: 66
Orexin receptor antagonists in the pathophysiology and treatment of sleep disorders and epilepsy
Mohammad Sheibani, Maryam Shayan, Mina Khalilzadeh, et al.
Neuropeptides (2023) Vol. 99, pp. 102335-102335
Closed Access | Times Cited: 18
Hypocretins, Neural Systems, Physiology, and Psychiatric Disorders
Shi‐Bin Li, Jeff R. Jones, Luı́s de Lecea
Current Psychiatry Reports (2016) Vol. 18, Iss. 1
Closed Access | Times Cited: 60
Future perspectives of emerging novel drug targets and immunotherapies to control drug addiction
Jonaid Ahmad Malik, Javed N. Agrewala
International Immunopharmacology (2023) Vol. 119, pp. 110210-110210
Closed Access | Times Cited: 15
Suvorexant, a Novel Dual Orexin Receptor Antagonist, for the Management of Insomnia
Andrew Hogyu Han, Caroline R. Burroughs, Evan P. Falgoust, et al.
Health psychology research (2023) Vol. 10, Iss. 5
Open Access | Times Cited: 13
Synthesis and Optical Properties of N-Arylnaphtho- and Anthra[2,3-d]oxazol-2-amines
Yuki Murata, Masato Kawakubo, Atsuko Maruyama, et al.
Molecules (2025) Vol. 30, Iss. 2, pp. 319-319
Open Access
Dual orexin receptor antagonists as promising therapeutics for Alzheimer’s disease
Sydney M. Ragsdale, John M. Radovich, Isabel I. Coiduras, et al.
Deleted Journal (2025) Vol. 2, Iss. 1
Open Access
Sleep Disorders in Patients With Posttraumatic Stress Disorder
Ali El-Solh, Usman Riaz, Jasmine Roberts
CHEST Journal (2018) Vol. 154, Iss. 2, pp. 427-439
Closed Access | Times Cited: 45
Effect of suvorexant on morphine tolerance and dependence in mice: Role of NMDA, AMPA, ERK and CREB proteins
Peyman Esmaili‐Shahzade‐Ali‐Akbari, Hossein Hosseinzadeh, Soghra Mehri
NeuroToxicology (2021) Vol. 84, pp. 64-72
Closed Access | Times Cited: 31
Ultrasound-assisted synthesis of substituted 2-aminobenzimidazoles, 2-aminobenzoxazoles, and related heterocycles
Wong Phakhodee, Chuthamat Duangkamol, Nittaya Wiriya, et al.
Tetrahedron Letters (2016) Vol. 57, Iss. 47, pp. 5290-5293
Closed Access | Times Cited: 34
Role of orexin in pathogenesis of neurodegenerative parkinsonisms
Piotr Alster, Natalia Madetko, Dagmara Otto‐Ślusarczyk, et al.
Neurologia i Neurochirurgia Polska (2023) Vol. 57, Iss. 4, pp. 335-343
Open Access | Times Cited: 9
2023 Guidelines on the Diagnosis and Treatment of Insomnia in Adults – Brazilian Sleep Association
Luciano F. Drager, Márcia Assis, Andrea Bacelar, et al.
Sleep Science (2023) Vol. 16, Iss. S 02, pp. 507-549
Open Access | Times Cited: 9
A male-specific mechanism of meningeal nociceptor sensitization promoting migraine headache
Caroline Machado Kopruszinski, Grace Lee, Laurent K. Martin, et al.
Cephalalgia (2024) Vol. 44, Iss. 9
Closed Access | Times Cited: 3
UPLC-MS/MS determination of suvorexant in urine by a simplified dispersive liquid-liquid micro-extraction followed by ultrasound assisted back extraction from solidified floating organic droplets
Muzaffar Iqbal, Essam Ezzeldin, Nasr Y. Khalil, et al.
Journal of Pharmaceutical and Biomedical Analysis (2018) Vol. 164, pp. 1-8
Closed Access | Times Cited: 31
Pharmacological profiling of zebrafish behavior using chemical and genetic classification of sleep-wake modifiers
Yuhei Nishimura, Shiko Okabe, Shota Sasagawa, et al.
Frontiers in Pharmacology (2015) Vol. 6
Open Access | Times Cited: 29
Improvement of glycemic control by treatment for insomnia with suvorexant in type 2 diabetes mellitus
Norikazu Toi, Masaaki Inaba, Masafumi Kurajoh, et al.
Journal of Clinical & Translational Endocrinology (2018) Vol. 15, pp. 37-44
Open Access | Times Cited: 29
One-pot reaction for the synthesis of N -substituted 2-aminobenzoxazoles using triphenylbismuth dichloride as cyclodesulfurization reagent
Yuki Murata, Natsuho Matsumoto, M. Miyata, et al.
Journal of Organometallic Chemistry (2018) Vol. 859, pp. 18-23
Closed Access | Times Cited: 27
Neuropeptide modulation of addiction: Focus on galanin
Shannyn G. Genders, Karlene J. Scheller, Elvan Djouma
Neuroscience & Biobehavioral Reviews (2018) Vol. 110, pp. 133-149
Closed Access | Times Cited: 24
Page 1 - Next Page

Scroll to top